Showing results (1691-1700 of 1,921) with videos related to

Sort By:
Pageof 193
Plos Genetics|June 23, 2023
Genetic regulators of sputum mucin concentration and their associations with COPD phenotypesEric Van Buren, Giorgia Radicioni, Sarah Lester, et al.
Chest|January 27, 2019
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICSSuresh Garudadri, Prescott G Woodruff, MeiLan K Han, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Plasma Cathelicidin is Independently Associated with Reduced Lung Function in COPD: Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortRobert M Burkes, Agathe S Ceppe, David J Couper, et al.
JAMA Oncology|January 18, 2019
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ TreatmentConstance D Lehman, Constantine Gatsonis, Justin Romanoff, et al.
Respiratory Research|June 21, 2017
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)Sean Duffy, Robert Marron, Helen Voelker, et al.
Circulation|April 2, 2020
Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart AssociationDhanunjaya R Lakkireddy, Mina K Chung, Rakesh Gopinathannair, et al.
Respiratory Research|November 21, 2018
Heterogeneous burden of lung disease in smokers with borderline airflow obstructionCheryl S Pirozzi, Tian Gu, Pedro M Quibrera, et al.
Plos One|April 13, 2018
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICSNirupama Putcha, Gabriel G Paul, Antoine Azar, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 6, 2020
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America RegionsArnaud Bourdin, Gerard Criner, Gilles Devouassoux, et al.
Rhinology|April 13, 2021
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNPM Desrosiers, L P Mannent, N Amin, et al.
Pageof 193